Stock Notes

Glenmark Pharmaceuticals

Every Finvezto stock note on Glenmark Pharmaceuticals, dated and newest first. Coverage spans pharma.

1 note and counting
11 Jun 2026
Glenmark launched Winlevi, its acne cream clascoterone, across key European markets including the Nordics, Spain and Central Europe, its first European NCE launch.
Winlevi is the first new topical acne mechanism in over 40 years, licensed from Cosmo Pharmaceuticals, opening a direct-sales beachhead in Europe for Glenmark.

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.